WeChat Mini Program
Old Version Features

Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study from the United Kingdom

Samuel Hsiang Lim,Beatriz Gros,Esha Sharma,Anouk Lehmann,James O. Lindsay,Louise Caulfield,Daniel R. Gaya,Jo Taylor,Jimmy Limdi,Jon Kwok, Elinor Shuttleworth,Anjan Dhar,Gemma Burdge,Christian Selinger,Sara Cococcia,Charles Murray,Karthiha Balendran,Tim Raine,Becky George,Gareth Walker, Robin Aldridge,Peter Irving,Charlie W. Lees,Mark Samaan

INFLAMMATORY BOWEL DISEASES（2023）

Cited 10|Views38
Key words
vedolizumab,subcutaneous,inflammatory bowel disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined